Brenda Johnson specializes in thyroid replacement therapy for individuals facing hypothyroidism or other thyroid hormone imbalances
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine beta-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer
Note: Product images are for illustrative purposes only
Product Overview Form: Injectable Liquid (10 mg per vial) Dosage: 2-3 mg per day, administered via subcutaneous injection Typical Cycle Duration : depends on individuals needs and goals
Patel, 2023)
PubMed Philp, D., Badamchian, M., Scheremeta, B., Nguyen, M., Goldstein, A.L., Kleinman, H.K